12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Igdrasol, Sorrento deal

Sorrento gained an exclusive option to acquire Igdrasol in a stock deal. Upon exercise, Sorrento will issue 76.2 million shares of its common stock to Igdrasol shareholders. The deal values Igdrasol at $18.3 million based on Sorrento's close of $0.24 on March 6, before the deal was announced. Igdrasol shareholders will also...

Read the full 240 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >